2019 annual financial data
Viking Therapeutics 2019 Net income growth
Direct answer
Net income growth was -16.84%.
Operating income was -32,686,999 USD and net income was -25,779,000 USD.
Operating cash flow was -24,752,000 USD.
Get free Viking Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -32,686,999 USD
- Net income
- -25,779,000 USD
- Operating cash flow
- -24,752,000 USD